Partner Headlines - AEZS

  1. UPDATE: Canaccord Genuity Reiterates Hold Rating, Raises ...

    Benzinga
  2. Mid-Day Market Movers

    Benzinga
  3. Benzinga's Top Pre-Market Gainers

    Benzinga
  4. Aeterna Zentaris Granted SPA by FDA for Phase 3 AEZS-108 ...

    Benzinga
  5. Benzinga's Top Pre-Market Gainers

    Benzinga
  6. Aeterna Zentaris Announces Final Phase 2 Data for ...

    Benzinga
  7. Aeterna Zentaris Presents Promising Results for ...

    Benzinga
  8. Stocks Hitting 52-Week Lows

    Benzinga
  9. Aeterna Zentaris Regains Compliance with NASDAQ $1.00 ...

    Benzinga
  10. Aeterna Zentaris Announces Pricing of US $16.5 Million ...

    Benzinga
  11. Benzinga's Top Pre-Market Losers

    Benzinga
  12. Aeterna Zentaris Announces Proposed Public Offering of ...

    Benzinga
  13. Benzinga's Microcap Movers for Thursday September 20, 2012

    Benzinga
  14. Benzinga's Microcap Movers for Monday August 14, 2012

    Benzinga
  15. Aeterna Zentaris Granted Patent in the U.S. for AEZS-130 ...

    Benzinga
  16. Six Flags Entertainment, Sanmina-SCI Corporation Among ...

    FOXBusiness
  17. Aeterna Zentaris Requests Fast Track Designation from ...

    Benzinga
  18. Benzinga's Microcap Movers for Tuesday June 26, 2012

    Benzinga
  19. Aeterna Zentaris Announces Final Phase 3 Results for ...

    Benzinga
  20. Aeterna Zentaris: Phase 1 Results Show Perifosine's ...

    Benzinga
  21. Aeterna Zentaris Receives Notification from NASDAQ ...

    Benzinga
  22. Keryx Biopharma Trade Lower after Adam Feuerstein's ...

    at Benzinga
  23. Aeterna Zentaris Reports Updated Phase 1 Trial Results ...

    at Benzinga
  24. Oppenheimer Reduces AEterna Zentaris PT

    at Benzinga
  25. Aeterna Zentaris Announces "At-the-Market" Issuance ...

    at Benzinga
Marketplace
Trading Center